Bayban’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Bayban's DGX Position: Q3 2026 in Review
Bayban held its Quest Diagnostics (DGX) position steady in Q3 2026 at 10 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #472.
Bayban first reported a position in DGX in Q4 2025 and has held it in 4 quarters since. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Bayban held 10 shares of Quest Diagnostics worth $2.33K as of Q3 2026.
- Bayban left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up ﹤0.01% of Bayban's portfolio in Q3 2026, its #472 holding.
- Bayban first reported a position in Quest Diagnostics in Q4 2025 and has held it in 4 quarters since.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.